Why the study?
Does blood-pressure-lowering treatment reduce cardiovascular and ESRD risk differently in hypertensive patients with versus without diabetes mellitus?
Does blood-pressure-lowering treatment reduce cardiovascular and ESRD risk differently in hypertensive patients with versus without diabetes mellitus?
Blood pressure lowering reduces cardiovascular risk in all hypertensive patients, but targeting SBP <130 mmHg provides additional benefit only in those without diabetes, challenging past recommendations.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Thomopoulos et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: